Mona Flores

Director at iOncologi

Capital raised by iOncologi

$3.3M+$250K latest round

2 Form D filings · first filed Feb 2025 · Gainsville, FL

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 4
FOUNDED: —
30D INTEREST: —

Career

1 company on file

iOncologiBiotech · Gainsville, FLsince Feb 2025

Director

Listed on iOncologi's Form D filings

Company filings

via EDGAR · Form D for iOncologi2

DateCompanyFormAmountRole on filing

May 8, 2025iOncologiForm D+$250K—

Form DMay 8, 2025 · iOncologi+$250Knot a signer

Feb 18, 2025iOncologiForm D+$3.0M—

Form DFeb 18, 2025 · iOncologi+$3.0Mnot a signer

Overview

Last filing May 8, 2025

Mona Flores is on file as Director at iOncologi in Gainsville, FL. iOncologi has 2 Form D filings on record, $3.3M raised in total.

Teammates

iOncologi · 3

Catherine FloresDirector Edgardo RodriguezChief Executive OfficerSigner Edgardo Rodriguez-LebronChief Executive OfficerSigner

Products

iOncologi · 1

IONC201 and IONC202Immunotherapy

IONC201 and IONC202 are advanced immunomodulatory stem cell therapies specifically designed to circumvent resistance to PD-1 blockade. They work by enhancing anti-tumor immune responses, offering a promising solution for patients who exhibit resistance to traditional immunotherapy.